Live Breaking News & Updates on Drug Initiative Program

To embed, copy and paste the code into your website or blog:
Arnall Golden Gregory LLP s Food & Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food & Drug practice, as well as from colleagues in other related life science disciplines. We are thinking of all of you in these difficult times, and hope that you and your loved ones are healthy and safe.
Industry Insights
Not a Very Happy Thanksgiving for One Pharmaceutical Company: OPDP Issues an Untitled Letter For Unlawful Promotion
Instead of sending a turkey and cranberry sauce, in the spirit of 2020 where nothing is normal, the Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) made a different delivery this year for Thanksgiving. It sent an Untitled Letter to a pharmaceutical company for sending a misleading email to healthcare professionals about the prescription drug’s risks and ef ....

United States , Belarus General , Genevievem Razick , Neilw Hoffman , Erine Doyle , Seths Ray , United States Department Of Health , Drug Administration Office Of Prescription Promotion , Centers For Medicare Medicaid Services , Us Department Of Health , Human Services , Drug Administration , Health Insurance Portability , Arnall Golden Gregory , Drug Initiative Program , Department Of Health , Office For Civil Rights , Drug Newsletter , Very Happy Thanksgiving , None Pharmaceutical Company , Untitled Letter For Unlawful , Prescription Drug Promotion , Untitled Letter , Interim Final Rule Implementing , Most Favored Nation Model , Medicaid Services ,